MA53513A - Combinaison à dose fixe et à libération immédiate de mémantine et de donépézil - Google Patents

Combinaison à dose fixe et à libération immédiate de mémantine et de donépézil

Info

Publication number
MA53513A
MA53513A MA053513A MA53513A MA53513A MA 53513 A MA53513 A MA 53513A MA 053513 A MA053513 A MA 053513A MA 53513 A MA53513 A MA 53513A MA 53513 A MA53513 A MA 53513A
Authority
MA
Morocco
Prior art keywords
memantine
donepezil
immediate
dose
fixed
Prior art date
Application number
MA053513A
Other languages
English (en)
Other versions
MA53513B1 (fr
Inventor
Machuco Estevens Maria Catarina Oliveira
Filipe Augusto Eugénio Pardal
Marques Da Costa Ricardo Manuel Silva
Serra João Pedro Silva
Original Assignee
Tecnimede Sociedade Tecnico Medicinal Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnimede Sociedade Tecnico Medicinal Sa filed Critical Tecnimede Sociedade Tecnico Medicinal Sa
Priority claimed from PCT/IB2020/055137 external-priority patent/WO2020240505A1/fr
Publication of MA53513A publication Critical patent/MA53513A/fr
Publication of MA53513B1 publication Critical patent/MA53513B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA53513A 2019-05-31 2020-05-29 Combinaison à dose fixe et à libération immédiate de mémantine et de donépézil MA53513B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT2019115557 2019-05-31
PCT/IB2020/055137 WO2020240505A1 (fr) 2019-05-31 2020-05-29 Combinaison à dose fixe et à libération immédiate de mémantine et de donépézil

Publications (2)

Publication Number Publication Date
MA53513A true MA53513A (fr) 2021-09-08
MA53513B1 MA53513B1 (fr) 2023-10-31

Family

ID=88650785

Family Applications (1)

Application Number Title Priority Date Filing Date
MA53513A MA53513B1 (fr) 2019-05-31 2020-05-29 Combinaison à dose fixe et à libération immédiate de mémantine et de donépézil

Country Status (7)

Country Link
ES (1) ES2960207T3 (fr)
HU (1) HUE063622T2 (fr)
LT (1) LT3843702T (fr)
MA (1) MA53513B1 (fr)
PL (1) PL3843702T4 (fr)
RS (1) RS64694B1 (fr)
SM (1) SMT202300336T1 (fr)

Also Published As

Publication number Publication date
MA53513B1 (fr) 2023-10-31
HUE063622T2 (hu) 2024-01-28
SMT202300336T1 (it) 2023-11-13
PL3843702T3 (pl) 2024-04-08
RS64694B1 (sr) 2023-11-30
LT3843702T (lt) 2023-11-10
ES2960207T3 (es) 2024-03-01
PL3843702T4 (pl) 2024-04-08

Similar Documents

Publication Publication Date Title
CL2020003257A1 (es) Compuestos antagonistas de pcsk9.
EP4045480A4 (fr) Formulations pharmaceutiques
IL284835A (en) Pharmaceutical combination comprising tno155 and ribociclib
EP4149460C0 (fr) Formes galéniques solides thérapeutiques
EP3904351A4 (fr) Inhibiteur de fak et combinaison de médicaments associée
KR20220012274A9 (ko) 플루오린 함유 화합물 및 이의 항암 의학적 용도
EP3881846C0 (fr) Composition pharmaceutique comprenant des inhibiteurs de parp
EP3737665A4 (fr) Promédicaments à base de kétamine, compositions et utilisations de ceux-ci
EP4072520C0 (fr) Compositions pharmaceutiques contenant du cabotégravir
EP4450498A4 (fr) Inhibiteur de parp, composition pharmaceutique le comprenant et son utilisation
EP3996695A4 (fr) Comprimés de cannabidiol à désintégration orale
EP3770148C0 (fr) Inhibiteur de récepteur, composition pharmaceutique le comprenant et son utilisation
EP3360907A4 (fr) Composition photodurcissable, base de prothèse dentaire et prothèse dentaire à plaque
EP4221690A4 (fr) Compositions pharmaceutiques
EP4074336A4 (fr) Composition pharmaceutique et son utilisation
EP3743136C0 (fr) Seringue de rinçage à élément désinfectant
IL311331A (en) Pharmaceutical composition and use thereof
EP3946344A4 (fr) Formulation de combinaison triple à faible dose
EP4135699A4 (fr) Compositions pharmaceutiques
EP3946343A4 (fr) Préparation à triple combinaison à faible dose
EP3746080A4 (fr) Formulations pharmaceutiques
EP4003293C0 (fr) Développement pharmaceutique
EP3849523A4 (fr) Compositions pharmaceutiques ophtalmiques à libération prolongée et utilisations associées
IL312874A (en) Pharmaceutical composition and use thereof
MA43114A (fr) Formulation combinée à dose fixe d'éflornithine et sulindac